TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/22/21 16:41 | 10/21/21 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nau Jeffrey | NJ | DO | P,CEO | M.d | 51 | 1.02 | 0 | 50 | 81 | 112 | D | ||||||||||||||
9/1/21 18:00 | 9/1/21 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nau Jeffrey | NJ | DO | P,CEO | M.d | 10 | 1.02 | 0 | 10 | 19 | 62 | D | ||||||||||||||
4/2/21 14:11 | 4/2/21 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nau Jeffrey | NJ | DO | P,CEO | M.d | 10 | 1.02 | 0 | 10 | 24 | 52 | D | ||||||||||||||
2/23/21 20:13 | 2/19/21 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nau Jeffrey | NJ | DO | P,CEO | M.d | 10 | 1.02 | 0 | 10 | 31 | 42 | D | ||||||||||||||
7/30/20 19:37 | 7/28/20 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nau Jeffrey | NJ | DO | P,CEO | M.d | 5 | 1.02 | 0 | 5 | 500 | 6 | D | ||||||||||||||
11/5/19 06:05 | 11/4/19 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nau Jeffrey | NJ | DO | P,CEO | P | 16 | 16.00 | 0 | 1 | New | 1 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |